Corporate drug distributors are the most profitable dealers on the street.
Negligent in their duties to monitor sales and encouraging their sales team to boost volume, they are finally being called out for their role in the 400,000 American deaths from opioids.
McKesson, Cardinal Health, and AmerisourceBergan distribute roughly 90 percent of drugs in the American healthcare system.
And they’re fat cats: when ranked by revenue, they are among the top 20 companies in the U.S.
Although the Society of Actuaries predicts that societal costs related to the opioid crisis will hit $188 billion just in 2019 alone, these distributors – along with Johnson & Johnson and Teva –agreed to only $260 million in reparations.
TRENDPOST: The corporate-controlled government of the United States – politicians paid with bribes that imbeciles call “campaign contributions” – have permitted Big Pharma to run, rule, and ruin America’s medical system.
The people of the United States are “legalized” drug addicts.
Negating the fact that no allotropic drug on the market cures a chronic degenerative disease, the pharmaceutical industry in the U.S. spends $30 billion a year on medical marketing.
Back in the 1990s, prescription drug expenditures were about $40 billion.
Today, it’s $360 billion.
Why the sharp spike?
Advertising sells. Just tune into the drug ads saturating TV.
It was that low-life, murderous, war monger, sellout, slimy Bill “Slick Willie” Clinton that permitted Big Pharma to run consumer ads on TV beginning in 1997.
Anyone watching the one-minute commercials knows the absurd 30-second list of side effects that follow the birds chirping, flowers blooming, and the actor dancing after swallowing the pills.
In 1996, Bill Clinton’s Food and Drug Administration approved the sale of OxyContin by Purdue Pharmaceuticals.
By 1998, following a promotional video of a doctor saying OxyContin does “not have serious medical side effects,” prescriptions jumped by 11 million.